News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
No one is Missed’s mission to ensure access to biomarker testing and treatment for NSCLC patients – LUNGevity Foundation
Jul 30, 2024, 07:19

No one is Missed’s mission to ensure access to biomarker testing and treatment for NSCLC patients – LUNGevity Foundation

LUNGevity Foundation shared on X:

“No One Missed is working to combat barriers to receiving biomarker testing and potentially life-saving treatment options for NSCLC patients. If you’ve been diagnosed, find a guide to help you start the discussion with your doctor.”

Proceed to the video attached to the post.
Source: LUNGevity Foundation/X

biomarker testing cancer life-saving treatment LUNGevity Foundation No One Missed NSCLC OncoDaily Oncology
Insight
Jul 30, 2024, 07:19
Thor Halfdanarson: Observation of small pancreatic NETs is becoming a standard
Blog
Jul 30, 2024, 07:19
No one is Missed's mission to ensure access to biomarker testing and treatment for NSCLC patients - LUNGevity Foundation
Blog
Jul 30, 2024, 07:14
Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Insight
Jul 30, 2024, 07:06
Aaron Goodman: An informative paper about CD19 CART timing of complications
Blog
Jul 30, 2024, 06:55
New episode of Oncology for the Inquisitive Mind podcast: Palliative Care with Dr. Janet Abrahm
Insight
Jul 30, 2024, 06:39
Ph II KUPENG trial of Vebreltinib in Advanced MetExon14 and NSCLC
Insight
Jul 30, 2024, 06:08
Mark Geyer: Practice-changing ECOG 1910 trial led by Mark Litzow
Blog
Jul 30, 2024, 05:58
Mark Chen: Back from a fantastic week at AACR MBCO 24
Blog
Jul 30, 2024, 05:47
GDUHEM day 2 continues
Blog
Jul 30, 2024, 02:53
Giannis Mountzios: Huge pleasure to discuss advances in Precision oncology in NSCLC with Elsa Anagnostou and Ferdinandos Skoulidis
Insight
Jul 30, 2024, 02:42
Why does Lionel Messi donate so much to charity?
Insight
Jul 30, 2024, 02:33
Study by Sylvester Comprehensive Cancer Center Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy